ARCHIVES

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 38 | October 6, 1989

Download PDF Visit The Full Archive

Related Articles

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

April 15, 2011

Existing HER2 Drugs May Help More In Breast Cancer Treatment

January 25, 2013

Opioid Pain Reliever Approved With Risk Reduction Plan

July 31, 2009

Concepts Approved For Developmental Therapeutics Program

June 19, 1987

NCAB Okays Effort To Relax $5 Million Limit On Center Core Grants In Cancer Act Renewal

November 19, 1976

Clinical Trials: Stories On Results Can Have Unintended Consequences

May 15, 1998